Freestone Grove Partners’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,724
Closed -$315K 724
2024
Q4
$315K Buy
+16,724
New +$315K ﹤0.01% 461